Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | F3 | P13726 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.39 |
| ▸ | STK17B | O94768 | 1/20 | 0.39 |
| ▸ | DUSP1 | P28562 | 1/20 | 0.38 |
| ▸ | DUSP6 | Q16828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4665877 | 1.00 | CYP1A2 (0.47) | CYP1A2MAPTCYP2D6CYP2C19LMNA | |
| SCHEMBL14080306 | 0.90 | MAPT (0.38) | CYP1A2MAPTCYP2D6CYP2C19LMNA | |
| SCHEMBL7839741 | 0.78 | MEN1 (0.38) | CYP1A2MAPTLMNASMN1; SMN2NPSR1 | |
| SCHEMBL1824532 | 0.77 | TDP1 (0.42) | CYP1A2MAPTCYP2D6CYP2C19LMNA | |
| SCHEMBL13299668 | 0.76 | NPC1 (0.50) | CYP1A2MAPTSMN1; SMN2HPGDF3 | |
| SCHEMBL22667801 | 0.74 | — | — | |
| SCHEMBL7839790 | 0.73 | ALDH1A1 (0.45) | CYP1A2MAPTLMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL7848396 | 0.69 | MAPT (0.45) | CYP1A2MAPTCYP2D6CYP2C19LMNA | |
| SCHEMBL7848283 | 0.69 | MAPT (0.45) | CYP1A2MAPTCYP2D6CYP2C19LMNA | |
| SCHEMBL9585267 | 0.68 | CYP1A2 (0.52) | CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 782 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108430448-B | Emulsion containing UV sun protection factor and carnosine | 西姆莱斯股份公司 | 2021-10-01 | — | — | CN | claimed |
| US-10857085-B2 | Preparations comprising carnosines | SYMRISE AG (DE) | 2020-12-08 | — | — | US | claimed |
| US-10688032-B2 | Emulsions having UV sunscreen factors and carnosines | SYMRISE AG (DE) | 2020-06-23 | — | — | US | claimed |
| US-20180369116-A1 | PREPARATIONS COMPRISING CARNOSINES | SYMRISE AG (DE) | 2018-12-27 | — | — | US | claimed |
| US-20180360723-A1 | EMULSIONS HAVING UV SUNSCREEN FACTORS AND CARNOSINES | SYMRISE AG (DE) | 2018-12-20 | — | — | US | claimed |
| EP-3389619-A1 | PREPARATIONS COMPRISING CARNOSINES | Symrise AG (DE) | 2018-10-24 | — | — | EP | claimed |
| EP-3389621-A1 | EMULSIONS HAVING UV SUNSCREEN FACTORS AND CARNOSINES | Symrise AG (DE) | 2018-10-24 | — | — | EP | claimed |
| US-20180221263-A1 | MEDICAMENT | SYMRISE AG (DE) | 2018-08-09 | — | — | US | claimed |
| US-20160166488-A1 | MEDICAMENT | SYMRISE AG (DE) | 2016-06-16 | — | — | US | claimed |
| EP-1296701-B1 | USE OF GRIFOLA FRONDOSA FUNGUS EXTRACTS | COGNIS FRANCE SAS (FR) | 2009-09-30 | — | — | EP | claimed |
| EP-1162941-B1 | SUN PROTECTION AGENTS | BIOTEC PHARMACON ASA (NO) | 2006-05-24 | — | — | EP | claimed |
| US-6500410-B1 | IMPROVING THE PHOTO SENSITIVITY AND SOLUBILITY OF UV LIGHT PROTECTION FACTOR IN SUN PROTECTING AGENTS COMPRISING INCLUDING WATER SOLUBLE BETA-(1,3) GLUCANS WHICH ARE SUBSTANTIALLY FREE FROM BETA-(1,6) LINKAGES | BIOTEC PHARMACON ASA (NO) | 2002-12-31 | — | — | US | claimed |
| US-5730960-A | SUNSCREEN AGENT | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1998-03-24 | — | — | US | claimed |
| EP-0693471-B1 | Benzylidene-norcamphor derivatives | MERCK PATENT GMBH (DE) | 1998-01-21 | — | — | EP | claimed |
| EP-3801448-B1 | WAX DISPERSIONS WITH CONDITIONING PROPERTIES | BASF SE (DE) | 2024-07-10 | — | — | EP | disclosed |
| EP-4376995-A1 | BIOBASED CORE-SHELL MICROCAPSULES | Symrise AG (DE) | 2024-06-05 | — | — | EP | disclosed |
| EP-4366690-A1 | POLYOL ESTER MIXTURE FOR USE AS VASELINE SUBSTITUTE | BASF SE (DE) | 2024-05-15 | — | — | EP | disclosed |
| US-5705169-A | REACTING FORMYLBENZALDEHYDE WITH KETOTRICYCLODECANE; DRUGS, COSMETICS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1998-01-06 | — | — | US | disclosed |
| EP-0693471-A1 | Benzylidene-norcamphor derivatives | MERCK PATENT GmbH (DE) | 1996-01-24 | — | — | EP | disclosed |
| EP-0693471-A1 | Benzylidene-norcamphor derivatives | MERCK PATENT GmbH (DE) | 1996-01-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180221263-A1 | MEDICAMENT | MMP2, MMP3, MMP10 | CYP1A2 295/4885MAPT 3308/4885CYP2D6 782/4885 |
| US-10688032-B2 | Emulsions having UV sunscreen factors and carnosines | F12, C1S, CCNI | CYP1A2 917/4885MAPT 1825/4885CYP2D6 2144/4885 |
| US-20180360723-A1 | EMULSIONS HAVING UV SUNSCREEN FACTORS AND CARNOSINES | F12, C1S, CCNI | CYP1A2 917/4885MAPT 1825/4885CYP2D6 2144/4885 |
| US-20180369116-A1 | PREPARATIONS COMPRISING CARNOSINES | C1R, C9, F12 | CYP1A2 1625/4885MAPT 958/4885CYP2D6 3619/4885 |
| US-10857085-B2 | Preparations comprising carnosines | C1R, C9, F12 | CYP1A2 1625/4885MAPT 958/4885CYP2D6 3619/4885 |
| US-20160166488-A1 | MEDICAMENT | MMP2, MMP3, MMP10 | CYP1A2 295/4885MAPT 3308/4885CYP2D6 782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.